FRID MIND TECHNOLOGIES
ActiveSummary
FRID MIND TECHNOLOGIES has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €817,176 and a net result of -€75,045. Equity is shrinking by about 16% per year across the filed financial years. Its solvency ranks better than 69% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
- Staff
- 0.8 FTE
- Equity
- €817,176
- Loss
- -€75,045
- Noureddine FridDirector
Why 92raises riskLoss of €75,045, the second in a row (financial year 2025)Liquidity: current ratio 1.03, cash €16,131lowers riskSize: total assets €1.2mFigures for financial year 2025 (filed 22-07-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 63% on solvency, 23% on liquidity, 25% on profitability and 35% on growth.
The bankruptcy probability was computed on 19-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 18 days after the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 33% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · abbreviated…
- Resignations: Marc Nolet, Pierre Lefebvre and…Share transfer · Director discharge
- Resignations: Marc Nolet, Pierre Lefebvre and…Share transfer · Director discharge…
Financials · financial year 2025, abbreviated format
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result stays negative: a loss of €81,046 in 2025 against €176,844 in 2024; the loss shrinks.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Average staff in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 72, Scientific research and development: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
- 2025 Net result +57% on 2024. The accounts now follow the abbreviated format, last year the micro format.
Peer companies
Historical observationOf the 6,910 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 90.9% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a small loss
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,472 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,910 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €43,360 | €18,852 | €10,810 | €16,259 | €74,108 | ▲ 356% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €412,876 | €525,874 | €516,415 | €496,281 | €333,417 | €225,304 | €93,772 | €43,078 | ▼ 54.1% |
| Other operating charges640/8 | - | - | - | €37,508 | €868 | €259 | €1,955 | €998 | ▼ 48.9% |
| Gross operating margin9900 | €148,236 | €143,303 | €3,733 | -€70,194 | -€21,562 | -€12,950 | -€64,858 | €37,139 | - |
| Operating profit (loss)9901 | -€500,798 | -€628,130 | -€610,597 | -€647,344 | -€374,699 | -€249,324 | -€176,844 | -€81,046 | ▲ 54.2% |
| Financial income75/76B | - | - | - | €129,664 | €127,454 | €59,887 | €4,339 | €5,286 | ▲ 21.8% |
| Recurring financial income75 | €71,451 | €102,307 | €121,772 | €129,664 | €127,454 | €59,887 | €4,339 | €5,286 | ▲ 21.8% |
| Non-recurring financial income76B | - | - | - | €0 | - | - | - | - | - |
| Financial charges65/66B | - | - | - | €3,937 | €7,980 | €7,495 | €2,916 | €3,225 | ▲ 10.6% |
| Recurring financial charges65 | €4,670 | €1,952 | €3,561 | €3,937 | €7,980 | €7,495 | €2,916 | €3,225 | ▲ 10.6% |
| Profit (loss) for the period before taxes9903 | -€434,018 | -€527,775 | -€426,892 | -€521,617 | -€255,225 | -€196,932 | -€175,421 | -€78,985 | ▲ 55.0% |
| Income taxes67/77 | -€22,912 | -€33,540 | -€36,956 | -€3,815 | -€2,182 | -€22,095 | €653 | -€3,940 | - |
| Profit (loss) for the period9904 | -€411,106 | -€494,235 | -€389,936 | -€517,802 | -€253,043 | -€174,837 | -€176,074 | -€75,045 | ▲ 57.4% |
| Profit (loss) for the period to be appropriated9905 | -€411,106 | -€494,235 | -€389,936 | -€517,802 | -€253,043 | -€174,837 | -€176,074 | -€75,045 | ▲ 57.4% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €2.8m | €2.5m | €2.2m | €1.6m | €1.2m | €1.3m | €1.1m | €1.2m | ▲ 4.7% |
| Fixed assets21/28 | €1.7m | €1.9m | €1.8m | €1.4m | €1.1m | €0.9m | €0.9m | €0.9m | ▲ 6.2% |
| Intangible fixed assets21 | €1.1m | €1.3m | €1.1m | €0.6m | €0.4m | €0.2m | €0.1m | €0.2m | ▲ 45.7% |
| Tangible fixed assets22/27 | €0.6m | €0.6m | €0.7m | €0.7m | €0.7m | €0.8m | €0.8m | €0.8m | ▼ 0.1% |
| Plant, machinery and equipment23 | - | - | - | €0.001m | €0 | €0.006m | €0.005m | €0.004m | ▼ 27.1% |
| Furniture and vehicles24 | - | - | - | €0.002m | €0.002m | €0.003m | €0.002m | €0.002m | ▲ 10.9% |
| Assets under construction and advance payments27 | - | - | - | €0.7m | €0.7m | €0.8m | €0.8m | €0.8m | = |
| Financial fixed assets28 | €0.002m | €0.002m | €0.002m | €0.002m | €0.002m | €0.002m | €0.002m | €0.002m | = |
| Current assets29/58 | €1.1m | €0.6m | €0.4m | €0.2m | €0.2m | €0.4m | €0.2m | €0.2m | ▼ 1.7% |
| Amounts receivable within one year40/41 | €0.9m | €0.5m | €0.4m | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | ▼ 8.6% |
| Trade receivables40 | - | - | - | €0.001m | €0.003m | €0 | - | €142 | - |
| Other amounts receivable41 | - | - | - | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | ▼ 8.6% |
| Cash at bank and in hand54/58 | €0.3m | €0.07m | €0.01m | €0.04m | €0.003m | €0.1m | €0.002m | €0.02m | ▲ 915% |
| Deferred charges and accrued income490/1 | - | - | - | €0.001m | €0.001m | €0 | €76 | €0 | ▼ 100% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €2.8m | €2.5m | €2.2m | €1.6m | €1.2m | €1.3m | €1.1m | €1.2m | ▲ 4.7% |
| Equity10/15 | €2.6m | €2.2m | €1.8m | €1.2m | €0.8m | €1.1m | €0.9m | €0.8m | ▼ 8.4% |
| Contributions10/11 | €3.2m | €3.2m | €3.2m | €3.2m | €3.2m | €3.7m | €3.7m | €3.7m | = |
| Capital10 | - | - | - | €3.2m | €3.2m | €3.7m | €3.7m | €3.7m | = |
| Issued capital100 | - | - | - | €3.2m | €3.2m | €3.7m | €3.7m | €3.7m | = |
| Uncalled capital101 | - | - | - | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | = |
| Profit (loss) carried forward14 | -€0.8m | -€1.3m | -€1.7m | -€2.2m | -€2.5m | -€2.6m | -€2.8m | -€2.9m | ▼ 2.7% |
| Investment grants15 | - | - | - | €0.2m | €0.06m | €0 | - | - | - |
| Amounts payable17/49 | €0.2m | €0.3m | €0.4m | €0.4m | €0.4m | €0.2m | €0.2m | €0.3m | ▲ 60.2% |
| Amounts payable after more than one year17 | - | - | - | - | - | - | - | €0.1m | - |
| Financial debts170/4 | - | - | - | - | - | - | - | €0.1m | - |
| Amounts payable within one year42/48 | €0.2m | €0.3m | €0.4m | €0.4m | €0.4m | €0.2m | €0.2m | €0.2m | ▲ 4.3% |
| Trade debts44 | €0.01m | €0.07m | €0.1m | €0.1m | €0.1m | €0.01m | €0.03m | €0.02m | ▼ 23.8% |
| Suppliers440/4 | - | - | - | €0.1m | €0.1m | €0.01m | €0.03m | €0.02m | ▼ 23.8% |
| Advances received on contracts in progress46 | - | - | - | - | €0.008m | €0 | - | - | - |
| Taxes, remuneration and social security45 | - | - | - | €0.03m | €0.04m | €0.01m | €0.01m | €0.03m | ▲ 121% |
| Taxes450/3 | - | - | - | €0.004m | €0.008m | €0.001m | €0 | €0.004m | - |
| Remuneration and social security454/9 | - | - | - | €0.02m | €0.03m | €0.01m | €0.01m | €0.02m | ▲ 87.3% |
| Other amounts payable47/48 | - | - | - | €0.2m | €0.2m | €0.2m | €0.2m | €0.2m | = |
| Accrued charges and deferred income492/3 | - | - | - | €0.007m | €0.01m | €0.01m | €0.01m | €0.02m | ▲ 14.1% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€411,106 | -€494,235 | -€389,936 | -€517,802 | -€253,043 | -€174,837 | -€176,074 | -€75,045 | ▲ 57.4% |
| + Depreciation and write-downs630 | €412,876 | €525,874 | €516,415 | €496,281 | €333,417 | €225,304 | €93,772 | €43,078 | ▼ 54.1% |
| Operating cash flow (approximation) | €1,770 | €31,639 | €126,479 | -€21,521 | €80,373 | €50,467 | -€82,302 | -€31,967 | ▲ 61.2% |
| Investment in fixed assets (approximation) | - | -€738,213 | -€381,117 | -€81,808 | -€45,960 | -€93,561 | -€39,710 | -€98,219 | ▼ 147% |
| Change in cash | - | -€181,880 | -€57,375 | €29,591 | -€37,014 | €129,307 | -€131,094 | €14,541 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (10)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 22-07-2026 | 2026-00345825 |
| 31-12-2024 | micro format | 29-08-2025 | 2025-00473513 |
| 31-12-2023 | micro format | 09-07-2024 | 2024-00236002 |
| 31-12-2022 | micro format | 13-07-2023 | 2023-00231948 |
| 31-12-2021 | micro format | 28-07-2022 | 2022-20250483 |
| 31-12-2020 | micro format | 13-08-2021 | 2021-48400077 |
| 31-12-2019 | micro format | 11-12-2020 | 2020-75300073 |
| 31-12-2018 | full format | 08-07-2019 | 2019-30300007 |
| 31-12-2017 | full format | 13-07-2018 | 2018-33500355 |
| 31-12-2016 | full format | 17-07-2017 | 2017-33900508 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Noureddine Fridfrom an act |
|
| Marc Nolet |
|
| Pierre Lefebvre |
|
| René-Pierre Azria |
|
Owners and capital
Capital and shareholders
- Marc Nolet to Bioradmedisys
- Pierre Lefebvre to Bioradmedisys
- René-Pierre Azria to Bioradmedisys
- Marc Nolet to Bioradmedisys
- Pierre Lefebvre to Bioradmedisys
- René-Pierre Azria to Bioradmedisys
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
Group and network
Connections & network
No directors read yet: 2 of 7 Gazette acts processed.
History
Acts, filings and financial milestones
06-07
Gazette deed
Resignations: Marc Nolet, Pierre Lefebvre and René-Pierre AzriaShare transfer · Director discharge11 facts ▸
- General meeting, 28-08-2025
- Director resignation, Marc Nolet (director)
- Director resignation, Pierre Lefebvre (director)
- Director resignation, René-Pierre Azria (director)
- Share transfer, Marc Nolet → Bioradmedisys
- Share transfer, Pierre Lefebvre → Bioradmedisys
- Share transfer, René-Pierre Azria → Bioradmedisys
- Director discharge, Marc Nolet
- Director discharge, Pierre Lefebvre
- Director discharge, René-Pierre Azria
- Director in office, Noureddine Frid (director)
24-06
Gazette deed
Resignations: Marc Nolet, Pierre Lefebvre and René-Pierre AzriaShare transfer · Director discharge · Registered-office move16 facts ▸
- General meeting, 28-08-2025
- Director resignation, Marc Nolet (director)
- Director resignation, Pierre Lefebvre (director)
- Director resignation, René-Pierre Azria (director)
- Share transfer, Marc Nolet → Bioradmedisys
- Share transfer, Pierre Lefebvre → Bioradmedisys
- Share transfer, René-Pierre Azria → Bioradmedisys
- Director discharge, Marc Nolet (director)
- Director discharge, Pierre Lefebvre (director)
- Director discharge, René-Pierre Azria (director)
- Board meeting, 10-06-2026
- Registered-office move, Rue Sart-Saint-Nicolas 44 à 6001 Charleroi
- +4 further facts in this act
Show earlier events
About the unread acts
Of the 7 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 18 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 92065B0056/00X004 | Wallonia | 2.1 ha | 1 · 418 m² | 5.6 m · 1 |
| 52058A1014/00B002 | Wallonia | 213 m² | 1 · 210 m² | 13.4 m · 4 |
How the parcels are linked
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- Other provision: Volet C, Nombre de pages volet B3 more provisions in the deed, see the deed of 24-06-2026
Read from the deeds: 4 provisions, deed of 24-06-2026